Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Completed · Phase 2

Conditions studied: Psoriasis

In brief

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Key facts

Study ID

NCT02785159

Run by

Bausch Health Americas, Inc.

People needed

152

Starts

2016-02-01

Expected to finish

2016-12-01

Last updated by the study team

2020-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Valeant Site 12 — Encino, California, United States
• Valeant Site 13 — Orange Park, Florida, United States
• Valeant Site 11 — Pinellas Park, Florida, United States
• Valeant Site 01 — Tampa, Florida, United States
• Valeant Site 04 — Tampa, Florida, United States
• Valeant Site 05 — Plainfield, Indiana, United States
• Valeant Site 09 — Clarkston, Michigan, United States
• Valeant Site 07 — Fridley, Minnesota, United States
• Valeant Site 14 — Saint Joseph, Missouri, United States
• Valeant Site 10 — Greenville, South Carolina, United States
• Valeant Site 03 — Murfreesboro, Tennessee, United States
• Valeant Site 06 — College Station, Texas, United States
• Valeant Site 08 — Webster, Texas, United States
• Valeant Site 02 — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.